엔에프씨 Stock: price and insider trades · South Korea
엔에프씨: what insiders have been doing
엔에프씨 is a Health Care company. Its directors and officers file their transactions with DART (FSS). From 2 November 2025 to 2 November 2026, the disclosure feed for 엔에프씨 logged 1 filing by 1 insider.
The flow runs one way only: 1 sale, from 1 insider, and no purchase. The totals exclude 1 filing filed without an amount.
Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 1 filing, this issuer sits below that mark. Since 2025, the database holds no purchases and 4 sales by insiders of the company.
A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About 엔에프씨
엔에프씨 is a company listed on the XKRX market, specializing in the healthcare and pharmaceutical sector.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
